Therapeutic Solutions International, Inc. reported the recruitment of stem cell pioneer and key opinion leader Francisco Silva to the Company's Scientific Advisory Board. Mr. Silva will join other Key Opinion Leaders such as Dr. Francesco Marincola of Gilead, Dr. Santosh Kesari who performs COVID-19 clinical trials, and Dr. Boris Reznik founder of two Inc. 500 companies. Mr. Silva currently serves as Vice President of Research and Development for BioRestorative Therapies.